Treatment of non-Hodgkin's lymphoma xenografts with the HB22.7 anti-CD22 monoclonal antibody and phosphatase inhibitors improves efficacy

Robert T O'Donnell, David Pearson, Hayes C. McKnight, Ya Peng Ma, Joseph Tuscano

Research output: Contribution to journalArticle

5 Scopus citations

Fingerprint Dive into the research topics of 'Treatment of non-Hodgkin's lymphoma xenografts with the HB22.7 anti-CD22 monoclonal antibody and phosphatase inhibitors improves efficacy'. Together they form a unique fingerprint.

Medicine & Life Sciences